TerrAscend Stock (CSE: TER) (OTC: TRSSF) - Investor Dashboard
|CEO:||Dr. Michael Nashat|
TerrAscend – Management Team
Dr. Michael Nashat – President & CEO
Michael is the former Executive Director of the OnPharm Independent Pharmacy Group, which represents the commercial interests of over 340 pharmacies with annual sales of over $300 million. Michael is a former board member with the Ontario College of Pharmacists, Canadian Foundation for Pharmacy, and the Canadian Association of Chain Drug Stores. He is also a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council, and currently serves as the Co-chair of the Ontario Pharmacists Association’s Owners Advisory Council. Michael has a Pharm.D. from the Albany College of Pharmacy and Health Science, and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Bristol Myers Squibb/Rutgers University in New Jersey, U.S.
Jeffrey Puglisi – Executive VP & Head of Operations
Over 30 years’ experience in the securities broker-dealer business. Co-founded Puglisi & Co., a New York based securities broker-dealer that specialized in investment banking, corporate finance, institutional trading and money management. Founded Puglisi Capital Partners, LP, a $200 million investment limited partnership focused on equity investments in both public and private companies. Held numerous FINRA securities licenses including Series 24 General Securities Principal, Series 27 Financial and Operations Principal, Series 66 Uniform Combined State Law Exam, Registered Investment Advisor (RIA)
Vijay Sappani – Chief Strategy Officer
Vijay Sappani is the Chief Strategy Officer of TerrAscend. Vijay held senior positions with Natco Pharma (Canada) Inc. and Biovail. He also served as Senior Special Assistant to the Ontario Minister of Health and Long Term Care and was a member of the board for the ministry’s Pharmacy Council as well as the Katz Group’s advisory council for self-distribution. Additionally, Vijay has served on the boards of several organizations and is an active community volunteer. Vijay has a B. Pharm. from the Tamil Nadu Dr. MGR Medical University in Chennai, India and a post-graduate diploma in Marketing Management from the Business School at Humber College.
Roland Nimmo CPA, CA – Interim Chief Financial Officer
Roland is a seasoned financial professional and has been a trusted advisor to numerous decision-makers in some of Canada’s largest, most prominent corporations. Roland holds a Honours Degree of Economics from Queens University and is a CPA, CA.
Jason Wild – Chairman
Pharmacist by training with significant pharmaceutical investment experience. President & Chief Investment Officer with JW Asset Management, LLC. Substantial experience supporting high growth pharmaceutical ventures through to profitability. Director of Arbor Pharmaceuticals and Vensun Pharmaceuticals.
Significant Insider Ownership
Chairman Jason Wild
34.7mm shares (JW Asset Management)
CEO Michael Nashat
4.04mm shares (Star-Pharma Pan-America Inc.)
CSO Vijay Sappani
5.01mm shares (Ela Family Trust)
3.96mm shares (Hanna Family Trust)
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.